FindTrial
Sign In

18F-AV-1451

DRUG8 trials

Sponsors

Institut National De La Sante Et De La Recherche Medicale, Avid Radiopharmaceuticals, Columbia University, University of Southern California, University of Pennsylvania

Conditions

Alzheimer DiseaseAlzheimer's pathologyCognition DisordersCognitive Impairment, MildDementia, MildFrontotemporal Dementia (FTD)Frontotemporal Lobar Degeneration (FTLD)Maladie d' Alzheimer

Phase 1

18F-AV-1451 PET Imaging in TBI
WithdrawnNCT02512029
Avid RadiopharmaceuticalsTraumatic Brain Injury
Start: 2015-10-31End: 2017-04-30Updated: 2016-02-05
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
CompletedNCT02850146
University of Southern CaliforniaCognition Disorders
Start: 2016-08-31End: 2023-09-29Updated: 2023-11-18
Tau PET Imaging in Atypical Dementias
CompletedNCT03283449
University of ChicagoPrimary Progressive Aphasia With Suspected Alzheimer's Disease
Start: 2016-02-29End: 2025-02-28Target: 70Updated: 2025-04-06

Phase 2

Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
CompletedNCT02676843
Columbia UniversityFrontotemporal Dementia (FTD), Frontotemporal Lobar Degeneration (FTLD), Tauopathies
Start: 2016-04-30End: 2018-11-25Updated: 2019-12-06
PET Tau - Neurodegenerative Disease Imaging
RecruitingNCT03143374
University of PennsylvaniaNeurodegenerative Disease
Start: 2016-08-23End: 2030-09-30Target: 300Updated: 2025-10-15
Tau PET Outcomes With Anti-amyloid Immunotherapies
Enrolling by invitationNCT06723015
Mayo ClinicAlzheimer Disease, Cognitive Impairment, Mild, Dementia, Mild
Start: 2025-11-04End: 2028-08-31Target: 135Updated: 2025-11-18
MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A MRI/PET STUDY
Not yet recruitingCTIS2024-519995-20-00
Institut National De La Sante Et De La Recherche MedicaleAlzheimer's pathology, Maladie d' Alzheimer
Target: 45Updated: 2025-01-29

Unknown Phase

Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans
CompletedNCT03287765
Tammie L. S. Benzinger, MD, PhDAlzheimer Disease
Start: 2016-05-31End: 2021-07-19Updated: 2023-05-08